Related Experiment Video
Updated: Jun 4, 2026

A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance
Published on: March 19, 2020
[Curing mental retardation: searching for balance]
1Université du Québec à Montréal, Département de chimie, Pharmaqam, Biomed, CP 8888, Succursale Centre-ville, Montréal, Québec H3C3P8, Canada.
Abstract:
Mental retardation (MR) occurs in 2 to 3 % of the general population and is still not therapeutically addressed. Milder forms of MR result from deficient synaptogenesis and/or impaired synaptic plasticity during childhood. These alterations would result from disequilibrium in signalling pathways regulating the balance between long term potentiation (LTP) and long term depression (LTD) in certain neurons such as hippocampus neurons. To provide mentally retarded children with increased cognitive abilities, novel experimental approaches are currently being developed to characterize signalling status associated with MR and to identify therapeutic targets that would restore lost equilibrium. Several studies also highlighted the major role played by molecular switches like kinases, phosphatases, small G proteins and their regulators in the coordination and integration of signalling pathways associated with synaptic plasticity. These proteins may therefore constitute promising therapeutic targets for a number of cognitive deficiencies.
Insights
Mental retardation (MR), affecting 2-3% of the population, is not yet treatable. Research focuses on synaptic plasticity and molecular pathways as potential therapeutic targets for cognitive enhancement.
Area of Science:
- Neuroscience
- Molecular Biology
- Developmental Disorders
Context:
- Mental retardation (MR) affects 2-3% of the general population with no current therapeutic interventions.
- Milder forms of MR are linked to impaired synaptogenesis and synaptic plasticity during childhood.
- These deficits disrupt the balance between long-term potentiation (LTP) and long-term depression (LTD) in neurons, particularly in the hippocampus.
Purpose:
- To identify novel experimental approaches for characterizing the signaling pathways involved in MR.
- To discover potential therapeutic targets that can restore synaptic plasticity and cognitive function.
- To investigate the role of molecular switches (kinases, phosphatases, G proteins) in synaptic plasticity regulation.
Summary:
- MR is associated with imbalances in signaling pathways that regulate synaptic plasticity, affecting cognitive abilities.
- Key molecular players, including kinases, phosphatases, and small G proteins, are crucial for coordinating these pathways.
- Deficiencies in these molecular switches contribute to the cognitive deficits observed in MR.
Impact:
- Identifying these molecular targets could lead to the development of treatments for cognitive deficiencies associated with MR.
- Restoring the equilibrium of synaptic plasticity pathways may enhance cognitive abilities in affected children.
- This research opens avenues for novel therapeutic strategies targeting molecular mechanisms of cognitive disorders.
Related Concept Videos
Self-Discrepancy Theory
Rational Emotive Behavior Therapy
Cognitive Dissonance
Regression Toward the Mean
Psychosis: Goals of Pharmacotherapy
Cognitive Development During Adulthood
